Stage III Melanoma molecular risk calculator
This molecular signature risk calculator provides a guide for health care professionals to assess a patient’s likely prognosis for Stage III melanoma based on gene expression markers. This work is supported by researchers from University of Sydney, The Westmead Millennium Institute for Medical Research and Melanoma Institute Australia (any additional group?)
How is this risk calculator constructed?
Details behind this risk calculator can be seen in Wang et al (2020) Cross-Platform Omics Prediction procedure enables precision medicine in Stage-III melanoma (manuscript in preparation).
Interpretation of the results of this calculator by those without appropriate medical and/or clinical training is not recommended. While care has been taken in preparing the content of this material University of Sydney, the Westmead Millennium Institute for Medical Research and Melanoma Institute Australia and their employees cannot accept any liability, including for any loss or damage, resulting from the reliance on the content, or for its accuracy, currency and completeness.